On the stock market since 2021, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
An average decline of 3% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
Executives buying with their own money is usually read as confidence in the company’s future.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $40.0M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 16 buys and 0 sells. Management buying with its own money is usually read as a good sign.
It pays out $1.22 per share each year — regular cash for whoever holds the stock.
A loss of $2.7M against $40.0M in annual sales.
The price action doesn’t yet back an upward turn.
On our five-subject report card, HTFB sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: HTFB is a high-risk stock — not yet profitable, and its future rides on its product catching on.